Laboratory of Clinical Biophysics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Int J Nanomedicine. 2011;6:2737-48. doi: 10.2147/IJN.S24537. Epub 2011 Nov 8.
Shedding of nanoparticles from the cell membrane is a common process in all cells. These nanoparticles are present in body fluids and can be harvested by isolation. To collect circulating nanoparticles from blood, a standard procedure consisting of repeated centrifugation and washing is applied to the blood samples. Nanoparticles can also be shed from blood cells during the isolation process, so it is unclear whether nanoparticles found in the isolated material are present in blood at sampling or if are they created from the blood cells during the isolation process. We addressed this question by determination of the morphology and identity of nanoparticles harvested from blood.
The isolates were visualized by scanning electron microscopy, analyzed by flow cytometry, and nanoparticle shapes were determined theoretically.
The average size of nanoparticles was about 300 nm, and numerous residual blood cells were found in the isolates. The shapes of nanoparticles corresponded to the theoretical shapes obtained by minimization of the membrane free energy, indicating that these nanoparticles can be identified as vesicles. The concentration and size of nanoparticles in blood isolates was sensitive to the temperature during isolation. We demonstrated that at lower temperatures, the nanoparticle concentration was higher, while the nanoparticles were on average smaller.
These results indicate that a large pool of nanoparticles is produced after blood sampling. The shapes of deformed blood cells found in the isolates indicate how fragmentation of blood cells may take place. The results show that the contents of isolates reflect the properties of blood cells and their interaction with the surrounding solution (rather than representing only nanoparticles present in blood at sampling) which differ in different diseases and may therefore present a relevant clinical parameter.
纳米颗粒从细胞膜上脱落是所有细胞中常见的过程。这些纳米颗粒存在于体液中,可以通过分离来收集。为了从血液中收集循环纳米颗粒,通常对血液样本进行多次离心和洗涤的标准处理。在分离过程中,血细胞也会释放纳米颗粒,因此尚不清楚分离材料中发现的纳米颗粒是在采样时存在于血液中,还是在分离过程中由血细胞产生的。我们通过确定从血液中收获的纳米颗粒的形态和特征来解决这个问题。
通过扫描电子显微镜观察分离物,通过流式细胞术进行分析,并通过理论确定纳米颗粒的形状。
纳米颗粒的平均尺寸约为 300nm,并且在分离物中发现了大量残留的血细胞。纳米颗粒的形状与通过最小化膜自由能获得的理论形状相对应,表明这些纳米颗粒可以被鉴定为囊泡。血液分离物中纳米颗粒的浓度和尺寸对分离过程中的温度敏感。我们证明,在较低的温度下,纳米颗粒的浓度更高,而纳米颗粒的平均尺寸更小。
这些结果表明,在采血后会产生大量的纳米颗粒。在分离物中发现的变形血细胞的形状表明了血细胞的碎裂可能如何发生。结果表明,分离物的内容反映了血细胞的特性及其与周围溶液的相互作用(而不是仅代表采样时血液中存在的纳米颗粒),在不同的疾病中有所不同,因此可能是一个相关的临床参数。